Results 21 to 30 of about 14,212 (288)
rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
Frontiers in Microbiology, 2022 Botulinum neurotoxin (BoNT) is one of the most dangerous bacterial toxins and a potential biological weapon component. BoNT mechanism of pathological action is based on inhibiting the release of neurotransmitters from nerve endings.
Artem A. Derkaev +9 more
doaj +1 more source
Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome [PDF]
International Neurourology Journal, 2015 Intravesical onabotulinumtoxinA (BoNT-A) injection is an effective treatment for overactive bladder syndrome (OAB) that is refractory to antimuscarinics.
Chun-Hou Liao, Hann-Chorng Kuo
doaj +1 more source
Applied Sciences, 2021 Botulinum toxins or neurotoxins (BoNTs) are the most potent neurotoxins known, and are currently extensively studied, not only for their potential lethality, but also for their possible therapeutic and cosmetic uses.
Massimo Corsalini +10 more
doaj +1 more source
Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis [PDF]
Investigative and Clinical Urology, 2020 After decades of clinical and basic science research, the clinical application of botulinum toxin A (Botox) in urology has been extended to neurogenic detrusor overactivity (NDO), idiopathic detrusor overactivity, refractory overactive bladder (OAB ...
Jing-Liang Chen , Hann-Chorng Kuo
doaj +1 more source
Toxins, 2023 DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A product containing daxibotulinumtoxinA with a stabilizing excipient peptide (RTP004).
Conor J. Gallagher +6 more
doaj +1 more source
Brazilian Oral Research, 2018 Botulinum toxin type A is effective in reducing excessive gingival display caused by hyperfunctional upper lip elevator muscles; however, this effect is transient.
Taísa Figueiredo Chagas +5 more
doaj +1 more source
Clinical Case Reports, 2020 The use of preoperative ventral botulinum toxin for giant hiatal hernia management.
Francisco Tustumi +8 more
doaj +1 more source
The positive effect of Botulinum toxin type A on the viability of random flap in tobacco exposed in rats [PDF]
Acta Cirúrgica Brasileira, 2016 PURPOSE: To evaluate the effect of Botulinum Toxin A in different time of tobacco exposure. METHODS: 60 male, Wistar rats were divided into two tobacco exposure groups: a 2- month or a 4-month regimen.
Cristina Pires Camargo +5 more
doaj +2 more sources
Toxins, 2022 Improvements in Botulinum toxin type-A (BoNT-A) aesthetic treatments have been jeopardized by the simplistic statement: “BoNT-A treats wrinkles”. BoNT-A monotherapy relating to wrinkles is, at least, questionable.
Alexander D. Nassif +3 more
doaj +1 more source
Toxins, 2021 The real-world use of onabotulinumtoxinA and incobotulinumtoxinA for cervical dystonia and blepharospasm treatment was assessed in two separate retrospective studies using identical protocols (TRUDOSE and TRUDOSE II). The studies were conducted in Mexico,
Ruth Kent +4 more
doaj +1 more source